Is biologic treatment of hidradenitis suppurativa during the COVID-19 pandemic different from psoriasis biologic treatment?
作者信息
Rosi Elia, Pimpinelli Nicola, Prignano Francesca
机构信息
Department of Health Sciences, Section of Dermatology, University of Florence, Florence, Italy.
出版信息
J Dermatolog Treat. 2022 Feb;33(1):599. doi: 10.1080/09546634.2020.1771256. Epub 2020 Jun 19.
Abstract
摘要
相似文献
1
Is biologic treatment of hidradenitis suppurativa during the COVID-19 pandemic different from psoriasis biologic treatment?
J Dermatolog Treat. 2022 Feb;33(1):599. doi: 10.1080/09546634.2020.1771256. Epub 2020 Jun 19.
2
Biologic drugs during COVID-19 outbreak.
Int J Dermatol. 2020 Oct;59(10):1293. doi: 10.1111/ijd.15088. Epub 2020 Aug 6.
3
Updates on treatment guidelines for psoriasis, atopic dermatitis (eczema), hidradenitis suppurativa, and acne/rosacea during the COVID-19 pandemic.
Dermatol Online J. 2020 Oct 15;26(10):13030/qt0j5150df.
4
Management of patients with hidradenitis suppurativa during the COVID-19 pandemic: Risk and benefit of immunomodulatory therapy.
Dermatol Ther. 2020 Nov;33(6):e14256. doi: 10.1111/dth.14256. Epub 2020 Sep 14.
5
Single-center survey of biologic use for inflammatory skin diseases during the coronavirus disease 2019 pandemic.
J Dermatol. 2021 Dec;48(12):1907-1912. doi: 10.1111/1346-8138.16159. Epub 2021 Sep 21.
6
Impact of the COVID-19 pandemic on the course and management of chronic inflammatory immune-mediated skin diseases: What's the evidence?
Clin Dermatol. 2021 Jan-Feb;39(1):52-55. doi: 10.1016/j.clindermatol.2020.12.012. Epub 2020 Dec 15.
7
[Impact of the COVID-19 Pandemic on Immunomodulatory and Immunosuppressive Therapies in Dermatology: Patient and Physician Attitudes in Argentina].
Actas Dermosifiliogr (Engl Ed). 2020 Nov;111(9):806-807. doi: 10.1016/j.ad.2020.04.004. Epub 2020 Apr 29.
8
No impact of immunomodulatory treatments on SARS-CoV-2 (COVID-19) vaccine outcomes: A cross-sectional analysis of biologic and small molecule inhibitors used for psoriasis and hidradenitis suppurativa patients from the Epic Cosmos database.
J Am Acad Dermatol. 2024 Jul;91(1):100-102. doi: 10.1016/j.jaad.2024.03.004. Epub 2024 Mar 13.
9
Biologics for patients affected by hidradenitis suppurativa in the COVID-19 era: data from a referral center of Southern Italy.
J Dermatolog Treat. 2022 Feb;33(1):592. doi: 10.1080/09546634.2020.1769828. Epub 2020 May 25.
10
Hidradenitis suppurativa: The importance of virtual outpatient care during COVID-19 pandemic.
J Am Acad Dermatol. 2020 Jul;83(1):e81-e82. doi: 10.1016/j.jaad.2020.04.142. Epub 2020 May 1.
引用本文的文献
1
Skin Manifestations in Psoriatic and HS Patients in Treatment with Biologicals during the COVID-19 Pandemic.
J Clin Med. 2021 Dec 13;10(24):5841. doi: 10.3390/jcm10245841.
2
Clinical Dermatology and COVID-19 Pandemic: Narrative Review.
Indian J Dermatol. 2021 May-Jun;66(3):246-255. doi: 10.4103/ijd.ijd_463_21.
Zotero 插件